Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2025-12-25 @ 3:55 AM
NCT ID:
NCT05550402
Eligibility Criteria:
Inclusion Criteria:
* Asthmatic patients classified by severity Mild (achieved control with using low-dose ICS or as-needed ICS-formoterol) or Moderate (achieved controlled with using low-dose ICS/LABA or Severe ((achieved controlled with using medium to high dose ICS/LABA)
* Post-bronchodilator (Salbutamol) FEV1/FVC ratio less than 0.75 or below the Lower Limit of Normal (LLN) and Post-bronchodilator (Salbutamol) FEV1 predicted \< 80% with or without bronchodilator response
* History of smoking less than 10 pack-years or current smoking
* Patients who able to do spirometry without contraindication
* asthma control was defined by ACQ6 \< 1.5
Exclusion Criteria:
* Contraindication for spirometry
* Chest x-ray suggested any chronic lung diseased
* Contraindication for anticholinergic drug
* History of asthma exacerbation within 12 weeks before visit 1
* History of taking LAMA within 6 months before visit 1
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT05550402
Study Brief:
Protocol Section:
NCT05550402